Synjardy

List of products in the National Drug Code with proprietary name synjardy. This medication is a combination of 2 drugs: empagliflozin and metformin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0597-0159Synjardy Empagliflozin And Metformin HydrochlorideTabletOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0168Synjardy Empagliflozin And Metformin HydrochlorideTabletOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0175Synjardy Empagliflozin And Metformin HydrochlorideTabletOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0180Synjardy Empagliflozin And Metformin HydrochlorideTabletOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0280Synjardy XREmpagliflozin, Metformin HydrochlorideTablet, Extended ReleaseOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0290Synjardy XREmpagliflozin, Metformin HydrochlorideTablet, Extended ReleaseOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0295Synjardy XREmpagliflozin, Metformin HydrochlorideTablet, Extended ReleaseOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0300Synjardy XREmpagliflozin, Metformin HydrochlorideTablet, Extended ReleaseOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug